Mette Kirstine Agger

CIK 1722234 · last filed 2025-10-07

Mette Kirstine Agger is a corporate insider who has filed 15 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for SCPH, was dated Oct 7, 2025. Across all open-market trades the lifetime net is +$15.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $40.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$40.75M

Companies

4

Total Filings

15

Lifetime Open-Market Net

$15.92M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
scPharmaceuticals Inc. (SCPH) Delisted Director 3,183,986 $5.67 $18.05M $9.17M 9 2025-10-07
LXEO Director $4.37 $0 3 2025-06-30
IMRA Director 1,432,722 $17.02 $24.38M $3.00M 1 2020-03-16
TRVI Director 1,151,544 $14.21 $16.36M $3.75M 2 2019-05-13

Recent Filings

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-10-07 scPharmaceuticals Inc. (SCPH) Delisted Disp (D) $0 EDGAR
2025-06-30 LXEO Grant (A) $0 EDGAR
2025-06-05 scPharmaceuticals Inc. (SCPH) Delisted Grant (A) $0 EDGAR
2024-06-27 LXEO Grant (A) $0 EDGAR
2024-06-13 scPharmaceuticals Inc. (SCPH) Delisted Grant (A) $0 EDGAR
2024-02-06 LXEO Grant (A) $0 EDGAR
2023-06-08 scPharmaceuticals Inc. (SCPH) Delisted Grant (A) $0 EDGAR
2020-06-11 scPharmaceuticals Inc. (SCPH) Delisted Grant (A) $0 EDGAR
2020-03-16 IMRA Mixed +1,432,722 $3.00M EDGAR
2019-06-20 scPharmaceuticals Inc. (SCPH) Delisted Grant (A) $0 EDGAR
Showing 110 of 15
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.